Skip to main content

US - English

Schedule & ETAMake a Payment Find a Facility
WM logo
SupportSupport
WM logo
Waste Management (WM) logo.

Products & Services

Residential Garbage & Recycling Pickup

Commercial Trash & Recycling Service

Roll-Off Dumpster Rentals

Bulk Pickup

Construction Waste Disposal

Bagster® - Dumpster in a Bag

eWaste

National Accounts

Moving In?

Customer Support

Pay My Bill

Billing & Invoice Help

Manage My Account

Log into MyWM

Customer Support

Request Extra Pickup

Report Missed Pickup

WM.com Security

Quick Info

Recycling 101

Our Service Areas

Find a Facility

10 Yard Dumpster

20 Yard Dumpster

30 Yard Dumpster

Holiday Schedule

Our Company

Who We Are

Media Room

WM Phoenix Open

Sustainability Report

Work With Us

Careers

Investors

Suppliers

Acquisitions & Divestitures

Former Employee HR Support

© 2026 WM Intellectual Property Holdings, LLC.

California Privacy Notice

Privacy Policy

Terms of Use

Service Terms & Conditions

Disputes/Arbitration

Accessibility

Sitemap

© 2026 WM Intellectual Property Holdings, LLC.

California Privacy Notice

Privacy Policy

Terms of Use

Service Terms & Conditions

Disputes/Arbitration

Accessibility

Sitemap

© 2026 WM Intellectual Property Holdings, LLC.

California Privacy Notice

Privacy Policy

Terms of Use

Service Terms & Conditions

Disputes/Arbitration

Accessibility

Sitemap

EPA Knowledge Center

EPA Knowledge Center

Overview

Final Rule: Subpart-P

Hazardous Drugs (NIOSH, USP 800)

Other Healthcare Hazardous Waste

External Resources

An Overview of Healthcare Related EPA Regulations

The Environmental Protection Agency (EPA) has a long history of regulating the disposal of pharmaceuticals, specifically through its enforcement of the Resource Conservation and Recovery Act (RCRA), the public law that creates the framework for the proper management of hazardous and non-hazardous solid waste.

Our EPA knowledge center is intended to keep the healthcare community informed on EPA regulations regarding pharmaceutical and other hazardous wastes generated in healthcare facilities. While not exhaustive, we hope it serves as a useful resource center and overview of related regulations and guidance by governing bodies. It’s critical for healthcare organizations to also stay abreast of local and state regulations on the generation and management of all wastes generated within their facilities.

Help Customers Stay EPA Compliant for Over 30 Years

For over 30 years, Stericycle has steadfastly strived to help keep our customers safe, compliant, while promoting sustainability. Our mission is rooted in protecting human health and well-being for the businesses and communities we serve. With that, we have a deep connection and respect for the EPA’s mission.

EPA works to ensure that:

  • Americans have clean air, land and water;
  • National efforts to reduce environmental risks are based on the best available scientific information;
  • Federal laws protecting human health and the environment are administered and enforced fairly, effectively and as Congress intended;
  • Environmental stewardship is integral to U.S. policies concerning natural resources, human health, economic growth, energy, transportation, agriculture, industry, and international trade, and these factors are similarly considered in establishing environmental policy;
  • All parts of society--communities, individuals, businesses, and state, local and tribal governments--have access to accurate information sufficient to effectively participate in managing human health and environmental risks;
  • Contaminated lands and toxic sites are cleaned up by potentially responsible parties and revitalized; and
  • Chemicals in the marketplace are reviewed for safety.

 

Stericycle was a pioneer of pharmaceutical disposal and to this day, we’re committed to the innovation of new products and services to help our client-partners reach their sustainability goals while properly disposing waste.

Together, we can prevent pharmaceutical waste from contaminating the environment and entering our waterways.

EPA Final Rule: Hazardous Waste Pharmaceuticals

The EPA Final Rule on Hazardous Waste Pharmaceuticals (Subpart P) and Amendment to the P075 Listing for Nicotine

The Final Rule of the Environmental Protection Agency (EPA), under 40 CFR 266 subpart P on the management of hazardous waste pharmaceuticals became effective on August 21, 2019.

The rule was effective immediately in AK, FL, IA, KY, NJ, PA, VA and Puerto Rico.

States that do not require legislation have until July 1, 2021 to adopt the rule, states that do require a legislative change in order to adopt the rule are given until July 1, 2022 to adopt.

As a result, the effective dates have varied by state. It's very important to understand that until your state adopts the rule, the current hazardous waste regulations are applicable.

The exception to state adoption is the ban on flushing. This requirement was proposed under the Hazardous and Solid Waste Amendments. Requirements implemented under this authority became effective in all states on August 21, 2019.

For more information, visit the EPA website.

1. Small and Large Quantity Generators (SQG and LQGs) that meet the EPA’s new definition of a health care facility or reverse distributor must manage their hazardous waste pharmaceuticals under new subpart P. 2. Very Small Quantity Generators (VSQGs) that meet the EPA’s new definition of health care facility or reverse distributor have the option of managing hazardous waste pharmaceuticals under new subpart P. 3. Facilities have less stringent options to dispose of containers with residual hazardous waste and p-listed wastes. 4. Controlled substances that are hazardous waste are conditionally exempted from being managed as such.

The rule is intended to provide health care specific regulations for the management of hazardous waste pharmaceuticals and help keep pharmaceuticals from entering our waterways. These tailored standards strive to make it easier and safer for health care facilities to follow, rather than the industrial-oriented hazardous waste generator regulations.

As defined in the final rule, the new regulations cover most health care entities that manage pharmaceutical products and waste such as hospitals, pharmacies, dentists, nursing facilities or long-term care facilities (LTCF), clinics and reverse distributors. The final rule does not apply to pharmaceutical manufacturers (unless they act as reverse distributors) or production facilities.

Under the new Final Rule, pharmaceutical waste (including P-listed wastes) does not count toward generator status. Hazardous waste from other areas of health care facilities and reverse distributors, such as solvents and other nonpharmaceutical waste, (e.g., products and other retail waste) will still be used to determine generator status.

The Final Rule bans the flushing (also called “sewering”) of all hazardous waste pharmaceuticals, regardless of generator type. This ban does not affect nonhazardous pharmaceuticals. However, the EPA discourages flushing of any pharmaceuticals. See WM’s infographic on the effects pharmaceutical waste has on the environment.

There are only a few controlled substances that are hazardous waste. These few drugs are conditionally exempted from hazardous waste regulations when managed in compliance with DEA regulations and incinerated at an authorized facility.

 

1. Stock, dispensing, and unit dose containers — this includes vials, blister packs, and dispensing bottles (not to exceed 1 liter or 10,000 pills). These items are considered empty when their contents have been removed by normal means and are not regulated as hazardous waste, even if they held P-listed wastes.

2. Syringes — syringes are considered empty and not regulated as hazardous waste pharmaceuticals when the plunger has been fully depressed. The empty syringe should be managed under applicable federal, state, and local requirements for medical waste and sharps.

3. Intravenous bags (IVs) — fully administered IV bags are considered empty and/or those that meet the current definition of RCRA empty.

4. Other containers, including delivery devices — this includes items such as inhalers, nebulizers, ointments, gels, and creams. These items are also considered empty when the current definition of RCRA empty is met.

Yes. The EPA amended the current listing for acutely hazardous nicotine and salts (P075) designating that FDA-approved, over-the-counter nicotine replacement therapies such as patches, gums and lozenges are no longer considered acutely hazardous waste.

This new exception applies to all generators of hazardous waste, not just healthcare facilities as it is outside of subpart P. Other nicotine containing products such as prescription replacement therapies and e-cigarettes are not excluded from the P075 listing and are still regulated as such. There is no requirement or timeline for state adoption.

Stay aware of your state's progress and potentially unique adoption of the Final Rule. It is very important to understand that all current RCRA regulations are being enforced until your state adopts. It is recommended that facilities potentially impacted by the Final Rule review the regulations.

 

To view the Final Rule and for additional information visit the EPA website.

 

Disposal of Hazardous Drugs Waste

The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs. These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. The list is further divided into 3 groups. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and meet other criteria from NIOSH to be considered an HD, and Group 3 includes non-antineoplastic drugs that are only reproductive hazards.

A drug that possesses any one of the following six characteristics is considered a hazardous drug, even if it does not appear on the NIOSH list:

• Genotoxicity

• Carcinogenicity

• Teratogenicity

• Fertility impairment or reproductive toxicity

• Serious organ toxicity at low doses

• Drugs with a chemical structure and profile that resemble other drugs known to be hazardous

The Environmental Protection Agency (EPA) regulates hazardous waste pharmaceutical disposal through the Resource Conservation and Recovery Act (RCRA). The law requires companies that use hazardous chemicals, including hazardous waste pharmaceuticals, to classify and dispose of them following prescribed criteria and procedures.

About 5% to 10% of pharmaceutical products can be classified as RCRA hazardous waste. EPA regulations do not require organizations to treat non-RCRA pharmaceutical waste as hazardous waste, though some States may have requirements. It is considered best practice to properly dispose of all pharmaceutical waste, whether RCRA or non-RCRA. Other agencies that regulate medicine waste disposal include the U.S. Department of Transportation (DOT), which covers how drug waste should be transported to waste management facilities, and the U.S. Drug Enforcement Administration (DEA), which oversees controlled substance waste management.

Trace Chemotherapy Waste

Drugs used in chemotherapy, including antineoplastics and cytotoxics, are potent and toxic agents that can cause serious health problems for employees if the drugs and drug waste are improperly handled and disposed of. To protect staff, healthcare organizations should have clear waste disposal processes that mitigate exposure risk.

How to dispose of Hazardous Drugs under USP 800?

The U.S. Pharmacopeia Convention (USP) is a scientific nonprofit organization with a mission “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” On December 1, 2019, General Chapter 800 of the USP published guidelines on handling hazardous drugs in healthcare settings. The standards set under the USP 800 should not be confused with and is unrelated to the regulations under the EPA Final Rule on Hazardous Waste Pharmaceuticals.

The USP 800 is a chapter of the USP that identifies best practices, setting industry standards for handling hazardous drugs (HDs) “to protect patients, healthcare personnel, and the environment.”

The USP does not enforce regulations. However, USP’s drug standards do influence and can be adopted by regulatory bodies including the Food and Drug Administration (FDA), state pharmacy boards and accrediting agencies such as Joint Commission.

WM monitors all federal and state regulations affecting your regulated waste management. If WM is servicing your facilities’ pharmaceutical waste and you are following the WM Waste Acceptance Policy, you are compliant with waste management regulations and current USP 800

standards concerning disposal. Be aware:

  • USP 800 is not a new set of regulations concerning pharmaceutical waste but rather new protocols for safe handling of pharmaceuticals in the clinical or pharmaceutical workplace.

  • Pharmaceutical waste will continue to be handled in accordance with EPA requirements, NIOSH guidelines, and individual state regulations.

  • WM strives to ensure our customers stay OSHA compliant, including with OSHA’s Hazard Communication Standard

For the safety of your employees and to stay compliant with the OSHA Hazard Communication Standard, you must keep an updated Hazard Communication Program (HCP). The USP 800 recommends only two additions: A written plan that describes how the USP 800 standard will be implemented and a provision that personnel of reproductive capability must confirm in writing that they understand the risks of handling hazardous drugs. Among other rules of the Hazard

Communication Standard, your HCP still needs to include:

  • All containers of hazardous chemicals must be labeled, tagged, or marked with the identity of the material and appropriate hazard warnings

  • Entities must have an safety data sheet (SDS) for each hazardous chemical they use (29 CFR 1910.1200)

  • Entities must ensure that the SDSs for each hazardous chemical used are readily accessible to personnel during each work shift and when they are in their work areas

  • Personnel who may be exposed to hazardous chemicals when working must be provided information and training before the initial assignment to work with a hazardous chemical, and also whenever the hazard changes.

USP 800 states that “handling hazardous drugs includes, but is not limited to, the receipt, storage, compounding, dispensing, administration, and disposal.” USP 800 refers primarily to transport and disposal within the healthcare facility but the standard does reflect WM’s long-standing recommendations as well as our Waste Acceptance Policy regarding hazardous drug wastage generated from chemotherapy.

Transport <800>, 11.3

“Hazardous drugs that need to be transported must be labeled, stored, and handled in accordance with applicable federal, state, and local regulations. HDs must be transported in containers that minimize the risk of breakage or leakage. Pneumatic tubes must not be used to transport any liquid hazardous drugs or any antineoplastic hazardous drugs because of the potential for breakage and contamination. When shipping hazardous drugs to locations outside the entity, the entity must consult the Transport Information on the SDS. The entity must ensure that labels and accessory labeling for the hazardous drugs include storage instructions, disposal instructions, and HD category information in a format that is consistent with the carrier’s policies.”

Disposal <800>, 11.4

“All personnel who perform routine custodial waste removal and cleaning activities in HD handling areas must be trained in appropriate procedures to protect themselves and the environment to prevent hazardous drug contamination. disposal of all hazardous drug waste, including, but not limited to, unused HDs and trace-contaminated PPE and other materials, must comply with all applicable federal, state, and local regulations.” Note: Disposal of all HD waste (including unused and unusable HDs) must comply with all applicable federal, state, and local regulations. Because USP 800 is not a regulation, and USP does not have jurisdiction over waste disposal, the standard defers to federal, state, and local regulations for waste disposal. This means that EPA regulations need to be followed for hazardous drug disposal that are also hazardous wastes. Some states also regulate waste that previously contained HDs or was used to administer HDs, in those states’ regulated medical waste regulations; this waste is often referred to as “trace chemotherapy” waste.

 

EPA Hazardous Waste Generator Improvements Rule

On May 30, 2017, the Hazardous Waste Generator Improvements Rule (HWGIR) was effective. EPA made over 60 revisions to the hazardous waste generator rules with this rulemaking. The goal of the changes was to improve compliance of generators by creating an improved user-friendly regulation; for example, the EPA has re-organized and consolidated definitions and regulations into one area for all generators. This guide is intended to provide a high-level overview of these changes.

States were required to adopt changes that are more stringent than the current regulations but did not have to incorporate changes that are less strict than current regulations. States adoption is not yet complete, please visit EPA’s site for the most current state adoption information.

ALERT: SQG RENOTIFICATION DUE BY SEPTEMBER 1, 2025

Under EPA’s Hazardous Waste Generator Improvements Rule, small quantity generators (SQGs, generating between 200 and 2200 lbs of non-acute hazardous waste per month) are now required to re-notify every four years. To satisfy this requirement, SQGs need to update their Notification of RCRA Subtitle C Activities (Site Identification Form), also known as EPA Form 8700-12, or state equivalent by September 1, 2025. This is required in states that have adopted the Hazardous Waste Generator Improvements Rule, a list of those states can be found here. The EPA's site on this topic can be found here.

Note: SQGs submitting Site ID forms in the four years prior to 2021 for another purpose, such as notifying as a healthcare facility under the 2019 Hazardous Waste Pharmaceuticals final rule, satisfy the re-notification requirement.

You may also be sent an email or postcard reminding of this requirement by the EPA and/or your state regulatory agency. Some states have electronic reporting options available for this notification.

Electronic Submittal Information

SQGs are encouraged to submit the re-notification electronically via MyRCRAID by logging into RCRAInfo and requesting MyRCRAID permissions for your site (if you have not already registered). You can log into or register for RCRAInfo here. Then, you should create a New Submission and select the option to provide a subsequent notification. The form will be pre-populated with the most recent information for your site in RCRAInfo.

Paper Submittal Information

SQGs should submit the Site ID Form and select the choice in Item 1 to obtain or update an EPA ID number. Complete the form with the current information for your site. Sign the form and submit it.

For more information and to see if this requirement is in effect in your state, contact your state or EPA regional office. Additional information regarding this requirement as well as the federal paper form can be found here.

More on The Waste Generator Improvements Rule

The HWGIR focuses on generators of hazardous waste; all three categories of hazardous waste generator will be affected. All generators of hazardous waste will be required to review their waste streams to make an “accurate” waste determination to identify if their wastes are characteristically hazardous or falls in one of the listed categories of waste.

There will remain three categories of generators and the quantities qualifying generators into these categories remain the same: Large Quantity Generator (LQG), Small Quantity Generator (SQG), and Very Small Quantity Generator (VSQG), which replaces the former term Conditionally Exempt Small Quantity Generator (CESQG). A generator must determine which category they belong to based on the amount of waste generated in a calendar month, the amounts do not differ from prior regulations. The proposed rule reorganizes these regulations and makes them easier to find and follow.

The section of regulations pertaining to a generator making hazardous waste determinations was expanded and revised. Emphasis was placed on the generator accurately determining if their solid waste is also a hazardous waste. SQGs and LQGs must document and maintain records of such determinations. These records must be kept for 3 years from the date the waste was last generated.

Under the HWGIR, SQGs and LQGs can accumulate as much as 55 gallons of non-acute hazardous waste and/or one quart of acute hazardous waste at or near the point of generation. The addition of “and/” is new and significant. The rules for container requirements did not change (closed, compatible with waste inside, in good condition) however additional requirements were added about incompatible wastes. Incompatible waste cannot be collected in the same container or in a container that previously held an incompatible waste or material, unless there is no chance of a reaction.

A container in an SAA must still be marked with the words “Hazardous Waste” but additional requirements were added. A container must also be marked with other words that provide an indication of the hazards of the contents; the waste characteristic, DOT labels and OSHA pictograms are given as examples.

Wastes that reach the accumulation amount limits in a SAA must be moved within three consecutive days of reaching their limit (and be marked with the date it reached the limit).

The term “Central Accumulation Area” or “CAA” was defined in the HWGIR; this area was previously noted as the 90- or 180-day accumulation area. Currently, both SQGs and LQGs are to inspect this area weekly. The indication of hazard labeling and marking noted above in the SAA section will also be required in the CAA.

A VSQG and SQG can take advantage of a new subpart, subpart L, to manage wastes in excess of their monthly generation limits without becoming subject to waste generation rules for a higher generation category. Only one episodic event is allowed per year, but a generator can petition the EPA for one additional event per year if that event is unplanned.

In order to comply, the generator must have an EPA ID number. At least 30 days prior to the event (or within 72 hours in the case of an unplanned emergency), the generator must notify EPA of the event. Waste can be collected in containers that must be in good condition, kept closed except to add or remove waste, and are compatible with the contents. Containers must also be marked with the words “Episodic Hazardous Waste”, an indication of hazards of the contents (ie. Waste characteristic, OSHA pictograms, DOT labels) and the date the event began.

The generator has 60 days to complete the episodic event, unless an extension is granted. Records of the event must kept for 3 years and include the following: beginning and end dates of the event, a description of the event, types and quantities of waste generated, a description of how the waste was managed and name of the facility that received it, name of the transporter, hazardous waste manifests and approval letters for the event from EPA.

Before transporting or offering a container for transport, an SQG or LQG must mark each container with all applicable waste codes. Generators can also use a nationally recognized electronic system such as bar coding to identify the EPA hazardous waste codes. Lab packs remain as they are required to be managed today.

The proposed rule requires both SQGs and LQGs to re-notify the EPA of their hazardous waste activities.. An SQG must re-notify starting in 2021 and then every four (4) years thereafter. LQGs must do so by March 1 of even-numbered years as part of their biennial report. This is done using form 8700-12, which has been revised to add this additional notification section and can be submitted as part of the Biennial Report.

 

New LQGs must have a quick reference guide for emergency responders. The SAA and CAA must be included as part of the emergency procedures. While LQGs must follow Subpart M – Preparedness, Prevention and Emergency Procedures, SQGs are not required to develop plans (there are still some emergency procedures that must be followed).

An LQG must notify the EPA 30 days prior to closing a unit, or place a note in their facility operating record; this also applies to the CAA but not SAAs. If the generator is closing the site, they must notify EPA within 90 days of completing the closure. Closure as a landfill is required if the facility fails to clean close.

 

The HWGIR allows a VSQG to ship their hazardous waste to an LQG that is under the control of the same person. VSQGs are generally not required to label their containers, but would need to comply with stricter labeling requirements when shipping waste to an LQG location. The LQG would need to notify the EPA 30 days prior to receiving the shipment via the 8700-12 form. The containers received must be labeled with the date they were received, the 90-day accumulation limit clock starts on this day. Records of shipments received including name, address and contact information for the VSQG, quantities and types received from VSQG must be kept by the LQG for 3 years. While no manifests are required when a VSQG ships to a LQG, the LQG are required to manage the waste as part of their waste stream and have all appropriate information prior to shipping off site for disposal.

 

Additional information regarding hazardous waste generation and applicable regulations can be found at www.epa.gov/hwgenerators.

EPA Knowledge Center: External Resources

EPA Final Rule: Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine

EPA Final Rule: Hazardous Waste Generator Improvements

EPA Guidance Documents

  • FAQ - Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine Final Rule

  • Managing Pharmaceutical Waste: A 10-Step Blueprint for Healthcare Facilities in the United States; revised August 2008

  • Pretreatment Program Factsheet on Hazardous Waste Reporting Requirements for Industrial Users under 40 CFR 403.12(p)&(j)

EPA Guidance Memos and Letters

  • Applicability of 40 CFR Part 266 Subpart P to Intermediate Care Facilities (PDF)

  • Chloral hydrate can be U034 (PDF)

  • Containers that Once Held P-listed Pharmaceutical Waste (PDF)

  • Cyclophosphamide monohydrate can be U058 (PDF)

WM Experts in the News

  • Waste 360: Navigating EPA’s Hazardous Waste Pharmaceuticals Rulemaking (Part One)

  • Waste 360: Navigating EPA’s Hazardous Waste Pharmaceuticals Rulemaking (Part Two)

  • Healthcare Purchasing News: Preparing for EPA’s final rule on hazardous waste pharmaceutical management

  • EPA's regulations on reverse distribution and policy on reverse logistics

  • Manifesting Non-Creditable Hazardous Waste Pharmaceuticals - New Four Character Code (PDF)

  • Medicinal nitroglycerine that does not exhibit the reactivity characteristic (D003) is not P081 (PDF) (2 pp, 19 K)

  • Nicotine as the sole active ingredient of E-liquids (PDF) (4 pp, 698 K)

  • Nicotine-containing products that are legitimately recycled are not solid waste (PDF)(3 pp, 586 K)

  • Scope of Hazardous Waste Listing P042 (Epinephrine) (PDF) (8 pp, 1.2 MB)

  • Scope of Hazardous Waste Listing P046 (Phentermine) (PDF)

  • EHS Today: New EPA Regulation Affects Healthcare Industry

  • McNight’s Long-Term Care News: How new hazardous waste pharmaceuticals rule will impact LTC

  • Environment + Energy Leader: What to Know about New Management Standards for Hazardous Waste Pharmaceuticals